Part of the INT²GRATE Oncology Consortium, the INT²GRATE Variant Portal provides a comprehensive assessment of variant actionability by integrating tumor and germline data, including detailed clinical evidence and analysis of differential and allelic conditions.

Part of the multi-institutional TCGenome program, the portal presents an aggregate database of genome variants from individuals who underwent universal cancer genetic testing and provides a comprehensive resource to support population-focused precision medicine.